Cempra Stock Trading Halted Today; FDA Advisory Committee

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cempra Stock Trading Halted Today; FDA Advisory Committee to Discuss Solithromycin

CHAPEL HILL, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq: CEMP ), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that NASDAQ has halted trading of the company's common stock.

The U.S. Food and Drug Administration's (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) is meeting today to discuss the safety and efficacy of solithromycin to treat community-acquired bacterial pneumonia (CABP).

The Advisory Committee meeting is scheduled to begin at 8:30 a.m. ET and is scheduled to end at 5:00 p.m. ET. The FDA briefing materials for the meeting can be found at: http://www.fda.gov/AdvisoryCommittees/Committ...496389.htm .

Solithromycin was granted qualified infectious diseases product (QIDP) designation which entitled the new drug applications (NDAs) to eight month priority reviews, resulting in PDUFA dates of December 27, and December 28, 2016, respectively, for the oral and intravenous NDAs. 

About Cempra, Inc. Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin has been successfully evaluated in two Phase 3 clinical trials for community acquired bacterial pneumonia and applications for approval for both intravenous and oral capsule formulations have been accepted for review by the FDA and the EMA. Solithromycin is licensed to strategic commercial partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in Japan. Solithromycin is also in a Phase 3 clinical trial for uncomplicated urogenital urethritis caused by Neisseria gonorrhoeae or chlamydia. Cempra is contracted with BARDA for the development of solithromycin for pediatric use. Three formulations, intravenous, oral capsules and a suspension formulation are in a Phase 1b trial in children from birth to 17 years of age. Fusidic acid is Cempra's second product candidate, which is being developed for acute bacterial skin and skin structure infections (ABSSSI) and is also in an exploratory study for chronic oral treatment of refractory infections in bones and joints. Both products seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra has also synthesized novel macrolides for non-antibiotic uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Cempra was founded in 2006 and is headquartered in Chapel Hill, N.C. For additional information about Cempra please visit www.cempra.com .

Please Note: This press release may contain forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: our and our strategic commercial partners' ability to obtain FDA and foreign regulatory approval of our product candidates, including solithromycin; results of our pre-clinical studies and clinical trials are not predictive of results from subsequent clinical trials for any possible therapy; and the costs, sources of funds, enrollment, timing, regulatory review and results of our studies and clinical trials and those of our strategic commercial partners. The reader is referred to the documents that we file from time to time with the Securities and Exchange Commission.

Contact: John Bluth Cempra, Inc. +1 984 209 4534 jbluth@cempra.com Investor Contact: Robert Uhl Westwicke Partners, LLC +1 858 356 5932 robert.uhl@westwicke.com Media Contact: Melyssa Weible Elixir Health PR +1 201 723 5805 mweible@elixirhealthpr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 75

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 142

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 141

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
SANY's Bold AI Showdown at bauma CHINA 2026

Updated Category News Views 27

SANY's Future Vision: AI Agents and Robotic Machinery The construction machinery game is about to get a whole lot smarter, if SANY has anything to say about it. They're rolling out their biggest show ever at bauma CHINA 2026, and the headline act? A fresh breed of AI agents and robotic machinery that promises to revolutionize the industry. Marking its 40-year legacy, SANY...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 89

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 62

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 301

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 128

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 104

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 112

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Market Fluctuations: NVIDIA, Micron, and SMCI Stocks Overview

Updated Category News Views 192

Market Update for NVIDIA, Micron, and SMCI Stocks Shares of NVIDIA Corp. (NASDAQ: NVDA), Super Micro Computer, Inc. (NASDAQ: SMCI), and Micron Technology, Inc. (NASDAQ: MU) have recently taken a noticeable dip. This drop has caught the eye of both investors and market analysts, leading to questions about what might be driving this trend. Current Hurdles in the...

Continue Reading
Hyundai Motor Shines at Cannes with Grand Prix and Gold Lions

Updated Category News Views 250

Hyundai Motor's Exceptional Recognition at Cannes Lions Hyundai Motor Company has made a remarkable impact at the prestigious Cannes Lions International Festival of Creativity. The company has achieved a Grand Prix award for its short film, 'Night Fishing,' a project that has been praised for its inventive storytelling and creative prowess. This Grand Prix marks a...

Continue Reading
EWTN's Expansion in Stockholm: A Strategic Faith Move

Updated Category News Views 54

A Bold Move into Northern Europe In what's shaping up to be a calculated leap of faith, the EWTN Global Catholic Network opened a new office in Stockholm, Sweden. Now, I don't usually get all warm and fuzzy over religious broadcasts, but this is less about spreading sermons and more about tapping into a growing market. Yeah, you heard me right—market. With the Catholic...

Continue Reading
Investors Urged to Act Now Amid 143% Cash Flow Decline

Updated Category News Views 135

Significant Concerns for StubHub Investors Investors in StubHub Holdings, Inc. (NYSE: STUB) are being urged to pay close attention as serious allegations surface concerning the company's recent financial disclosures. The prominent investor rights law firm Hagens Berman is reaching out to those investors who acquired shares during the company's Initial Public Offering...

Continue Reading
Walmart Leverages Automation to Rival Amazon's Dominance

Updated Category News Views 200

Walmart Ignites Technological Transformation Walmart Inc (NYSE: WMT) is not just a retailer; it's transforming into a technology powerhouse. While many might think of Amazon.com Inc (NASDAQ: AMZN) as the leader in tech-driven logistics, Walmart is ramping up its efforts. Recently, during a call with investors, the company's CFO highlighted a key milestone: "More than 50%...

Continue Reading